Tumour vaccines represent a therapeutic strategy aimed at eliminating tumour cells by activating or enhancing the immune response against the tumour, including the expansion of antigen-specific CD4+ and CD8+ T cells [122]. This evidence concerns the gene CD8A and neoplasm.